Alzamend Neuro (ALZN) Earnings Date & Reports

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALZN is expected to report earnings to rise 17.86% to -66 cents per share on December 30

Alzamend Neuro ALZN Stock Earnings Reports

Q4'26

Est.

$-0.66

Q3'26

Beat

by $0.11

Q2'26

Missed

by $0.30

Q1'26

Missed

by $0.16

Q4'25

Beat

by $0.31

The last earnings report on September 15 showed earnings per share of -56 cents, beating the estimate of -67 cents. With 160.78K shares outstanding, the current market capitalization sits at 8.35M.

View a ticker or compare two or three

ALZN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ALZN